One of the major mechanisms of cell death that has been implicated in several neurodegenerative disorders, including Alzheimer's disease, is glutamate-receptor mediated excitotoxicity. Until recently it was not feasible to delineate with precision the glutamate receptor subunit profile of identified neurons and circuits in the cerebral cortex. However, with the molecular characterization of the specific subunit proteins and the development of riboprobes and subunit specific antibodies, it is now feasible to develop detailed glutamate receptor profiles of both vulnerable and resistant neurons that are subunit-and family-specific that will delineate the degree to which certain glutamate receptor subunit molecules might be implicated in the differential vulnerability that is apparent in Alzheimer's disease. Within this context this project will be directed at the four major goals. 1) Screening of monoclonal antibodies that are directed against subunits of the non-NMDA(GluR1-7) and NMDA families of glutamate receptors for their effectiveness in immunohistochemical studies of human cortex. 2) These immunohistochemical probes, as well as riboprobes, will be used to analyze the regional, laminar and cellular distribution of specific glutamate receptor subunit proteins and related mRNAs in monkey and human neocortex and hippocampus. 3) Double labelling paradigms will be employed to determine the comprehensive glutamate receptor profile a well as correlations between the presence of certain glutamate receptor subunits and other neurochemical characteristics that have been correlated with either vulnerability or resistance to degeneration in Alzheimer's disease. These studies initially will concentrate on colocalization with cytoskeletal and Ca+2-binding proteins. 4) Alzheimer's disease related changes in the dendritic, cellular, laminar, or regional distribution of such subunit proteins and/or related mRNA's will be determined through comparison of immunohistochemical patterns in brains from Alzheimer's disease patients, elderly controls, and young controls. Through this combined analysis of normative human material, Alzheimer's disease tissue, and genetically manipulated mice it is hoped that we will be able to develop a precise glutamate receptor profile that can be linked to the differential vulnerability apparent in Alzheimer's disease and within this context develop quantitative data on shifts in the expression of specific subunits and related glutamate receptor families that might be causally related to the neurodegeneration of specific subsets of cortical neurons that occurs in Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005138-13
Application #
5204474
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Wang, Jen-Chyong; Alinaghi, Somayeh; Tafakhori, Abbas et al. (2018) Genetic screening in two Iranian families with early-onset Alzheimer's disease identified a novel PSEN1 mutation. Neurobiol Aging 62:244.e15-244.e17
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Huang, Qian; Voloudakis, Georgios; Ren, Yimin et al. (2018) Presenilin1/?-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15. FASEB J 32:243-253
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545

Showing the most recent 10 out of 555 publications